From Faith in Healthcare (https://faithinhealthcare.org):
The Medicare Part D prescription drug program could have saved $14.4 billion in 2016 by negotiating its costs as the VA did, according to a new study in JAMA Internal Medicine. Drug industry lobbying power led to current U.S. law blocking Medicare from negotiating drug prices, which is at the core of VA savings and the far lower drug costs paid in other countries. Polls consistently show widespread, bipartisan support for changing the law, and unleashing the U.S.’ bargaining power on drug prices.
Leave a Reply